Dick7Access
Dick S
- Local time
- Today, 13:41
- Joined
- Jun 9, 2009
- Messages
- 4,264
has president Trump shut down any cancer research
Why would he do that? You are believing the TDS twist (and now the MDS twist) the media and the Dems put on everything. Do you think that it is only the government that funds research? Do you think that the government should always fund all scientific research? Do you think we should pay for all types of research regardless of the goal? Do you think research should favor cures rather than treatments?has president Trump shut down any cancer research
The pharmaceutical companies will not allow for a cure for the common cold, more less cancer. Sorry if this is what you are thinking.
A cure provides 1 payday but treating the symptoms is a gift that keeps on giving. Also, keep in mind that Americans pay the highest drug prices of any other country in the world despite how much money we give the drug companies for R&D. Someone needs to fix this. Maybe if we provide 50% of the R&D money for a new drug, we should get 50% of the profits when it gets to market. Also the patent laws need to change. The patent period kicks in when the testing starts but it could be a decade before the drug hits the market and so the drug company then has 5 years or less to recoup their investment before the patent expires. That's just not right and dramatically increases the cost for new drugs.Yeah, I get it. I also understand it's not in their best interest to cure anything.
It's collateral damage.has president Trump shut down any cancer research
And yet Trump, in his first term, issued an EO that gave very ill patients the "right to try" unapproved treatments. Too bad Congress won't make this into law.It's collateral damage.
Just plain heresySomehow or another the government needs to spend less money.
And yet Trump, in his first term, issued an EO that gave very ill patients the "right to try" unapproved treatments. Too bad Congress won't make this into law
On May 22, the Senate passed S.204, the Trickett Wendler, Frank Mongiello, Jordan McLinn and Matthew Bellina Right to Try Act, and sent it to President Trump, who signed it on May 30, 2018, creating a uniform system for terminal patients seeking access to investigational treatments.
According to Scott Gottlieb, who served as commissioner of the FDA under President Donald Trump, before the right-to-try law, the FDA already approved 99% of patient requests for access to experimental drugs, either immediately over the phone or within a few days.